These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17478886)

  • 1. Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.
    Marvanova M; Nichols CD
    J Mol Neurosci; 2007; 31(2):127-37. PubMed ID: 17478886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans.
    Li H; Feng Y; Chen Z; Jiang X; Zhou Z; Yuan J; Li F; Zhang Y; Huang X; Fan S; Wu X; Huang C
    Pharmacol Res; 2021 Jan; 163():105220. PubMed ID: 33007422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
    Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
    CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.
    Benedetto A; Au C; Avila DS; Milatovic D; Aschner M
    PLoS Genet; 2010 Aug; 6(8):. PubMed ID: 20865164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans.
    Cao S; Gelwix CC; Caldwell KA; Caldwell GA
    J Neurosci; 2005 Apr; 25(15):3801-12. PubMed ID: 15829632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Bano S; Shukla S
    Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease.
    Tsai CW; Tsai RT; Liu SP; Chen CS; Tsai MC; Chien SH; Hung HS; Lin SZ; Shyu WC; Fu RH
    Cell Transplant; 2017 Dec; 26(12):1903-1918. PubMed ID: 29390878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson's disease.
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    Neurotoxicology; 2022 Dec; 93():128-139. PubMed ID: 36108815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.
    Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Kimura J; Shimohama S
    Ann Neurol; 1998 Jul; 44(1):110-9. PubMed ID: 9667598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
    Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scorpion venom heat-resistant synthetic peptide protects dopamine neurons against 6-hydroxydopamine neurotoxicity in C. elegans.
    Guo SY; Guan RX; Chi XD; Yue-Zhang ; Sui AR; Zhao W; Supratik K; Yang JY; Zhao J; Li S
    Brain Res Bull; 2022 Nov; 190():195-203. PubMed ID: 36191729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.
    Yu H; Liu X; Chen B; Vickstrom CR; Friedman V; Kelly TJ; Bai X; Zhao L; Hillard CJ; Liu QS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing.
    Chalorak P; Jattujan P; Nobsathian S; Poomtong T; Sobhon P; Meemon K
    Nutr Neurosci; 2018 Jul; 21(6):427-438. PubMed ID: 28276260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ; Fox SA; Caldwell GA; Caldwell KA
    Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
    Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
    Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole protects dopaminergic neurons through paraplegin against 6-hydroxydopamine.
    Kim MK; Park HS; Cho JH; Kim GS; Won C
    Neuroreport; 2015 Jan; 26(2):74-80. PubMed ID: 25514384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.